These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25014180)

  • 21. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
    Youngster I; Mahabamunuge J; Systrom HK; Sauk J; Khalili H; Levin J; Kaplan JL; Hohmann EL
    BMC Med; 2016 Sep; 14(1):134. PubMed ID: 27609178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
    Suchman K; Luo Y; Grinspan A
    Dig Dis Sci; 2022 Oct; 67(10):4866-4873. PubMed ID: 35000023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive.
    Brumbaugh DE; De Zoeten EF; Pyo-Twist A; Fidanza S; Hughes S; Dolan SA; Child J; Dominguez SR
    J Pediatr; 2018 Mar; 194():123-127.e1. PubMed ID: 29198534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
    Cappetto CM
    Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience.
    Patel NC; Griesbach CL; DiBaise JK; Orenstein R
    Mayo Clin Proc; 2013 Aug; 88(8):799-805. PubMed ID: 23910407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.
    Cammarota G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2014 Sep; 48(8):693-702. PubMed ID: 24440934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
    Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
    J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.
    Fischer M; Sipe B; Cheng YW; Phelps E; Rogers N; Sagi S; Bohm M; Xu H; Kassam Z
    Gut Microbes; 2017 May; 8(3):289-302. PubMed ID: 28001467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.
    Weingarden AR; Chen C; Bobr A; Yao D; Lu Y; Nelson VM; Sadowsky MJ; Khoruts A
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G310-9. PubMed ID: 24284963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
    Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.
    Youngster I; Russell GH; Pindar C; Ziv-Baran T; Sauk J; Hohmann EL
    JAMA; 2014 Nov; 312(17):1772-8. PubMed ID: 25322359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.
    Nicholson MR; Mitchell PD; Alexander E; Ballal S; Bartlett M; Becker P; Davidovics Z; Docktor M; Dole M; Felix G; Gisser J; Hourigan SK; Jensen MK; Kaplan JL; Kelsen J; Kennedy M; Khanna S; Knackstedt E; Leier M; Lewis J; Lodarek A; Michail S; Oliva-Hemker M; Patton T; Queliza K; Russell GH; Singh N; Solomon A; Suskind DL; Werlin S; Kellermayer R; Kahn SA
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):612-619.e1. PubMed ID: 31009795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
    Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.
    Drekonja D; Reich J; Gezahegn S; Greer N; Shaukat A; MacDonald R; Rutks I; Wilt TJ
    Ann Intern Med; 2015 May; 162(9):630-8. PubMed ID: 25938992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.